JP2021523702A5 - - Google Patents

Info

Publication number
JP2021523702A5
JP2021523702A5 JP2020561751A JP2020561751A JP2021523702A5 JP 2021523702 A5 JP2021523702 A5 JP 2021523702A5 JP 2020561751 A JP2020561751 A JP 2020561751A JP 2020561751 A JP2020561751 A JP 2020561751A JP 2021523702 A5 JP2021523702 A5 JP 2021523702A5
Authority
JP
Japan
Prior art keywords
epitope
seq
aavx
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020561751A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523702A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/030955 external-priority patent/WO2019213668A1/en
Publication of JP2021523702A publication Critical patent/JP2021523702A/ja
Publication of JP2021523702A5 publication Critical patent/JP2021523702A5/ja
Priority to JP2024079802A priority Critical patent/JP2024119818A/ja
Pending legal-status Critical Current

Links

JP2020561751A 2018-05-04 2019-05-06 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ Pending JP2021523702A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024079802A JP2024119818A (ja) 2018-05-04 2024-05-15 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862667360P 2018-05-04 2018-05-04
US62/667,360 2018-05-04
PCT/US2019/030955 WO2019213668A1 (en) 2018-05-04 2019-05-06 Human anti-aav2 capsid polyclonal antibody epitopes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024079802A Division JP2024119818A (ja) 2018-05-04 2024-05-15 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ

Publications (2)

Publication Number Publication Date
JP2021523702A JP2021523702A (ja) 2021-09-09
JP2021523702A5 true JP2021523702A5 (enExample) 2022-05-16

Family

ID=68386753

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020561751A Pending JP2021523702A (ja) 2018-05-04 2019-05-06 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ
JP2024079802A Pending JP2024119818A (ja) 2018-05-04 2024-05-15 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024079802A Pending JP2024119818A (ja) 2018-05-04 2024-05-15 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ

Country Status (5)

Country Link
US (1) US20210292370A1 (enExample)
EP (1) EP3799568A4 (enExample)
JP (2) JP2021523702A (enExample)
CN (1) CN112351787A (enExample)
WO (1) WO2019213668A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113166208B (zh) 2018-10-02 2024-11-22 沃雅戈治疗公司 重新定向aav衣壳的嗜性
CA3161367A1 (en) * 2019-12-10 2021-06-17 Homology Medicines, Inc. Adeno-associated virus compositions and methods of use thereof
CA3177268A1 (en) 2020-05-05 2021-11-11 The University Of North Carolina At Chapel Hill Modified adeno-associated virus 5 capsids and uses thereof
US12630842B2 (en) 2020-05-13 2026-05-19 Voyager Therapeutics, Inc. Redirection of tropism of AAV capsids
CN113583112B (zh) * 2021-07-30 2022-07-19 上海勉亦生物科技有限公司 Aav特异性抗体及其应用
CN113999861B (zh) * 2021-09-08 2024-03-15 三峡大学 腺相关病毒衣壳蛋白保守区多克隆抗体的制备方法及应用
EP4426716A1 (en) 2021-11-02 2024-09-11 Voyager Therapeutics, Inc. Aav capsid variants and uses thereof
CN114685651B (zh) * 2022-04-15 2023-07-11 三峡大学 一种特异识别aav9衣壳蛋白的多克隆抗体及制备方法
JPWO2025100417A1 (enExample) * 2023-11-06 2025-05-15

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7749492B2 (en) * 2001-01-05 2010-07-06 Nationwide Children's Hospital, Inc. AAV vectors and methods
EP1828390B1 (en) * 2004-12-15 2012-06-13 The University Of North Carolina At Chapel Hill Chimeric vectors
US9725485B2 (en) * 2012-05-15 2017-08-08 University Of Florida Research Foundation, Inc. AAV vectors with high transduction efficiency and uses thereof for gene therapy
CN103502458B (zh) * 2011-02-17 2016-11-16 宾夕法尼亚大学托管会 用于改变组织特异性和改善aav9-介导的基因转移的组合物和方法
EP2660325A3 (en) * 2012-05-02 2014-02-12 Christian Medical College AAV vectors and corresponding nucleotide sequences and methods
US11136557B2 (en) * 2013-05-31 2021-10-05 The Regents Of The University Of California Adeno-associated virus variants and methods of use thereof
US10746742B2 (en) * 2014-04-25 2020-08-18 Oregon Health & Science University Methods of viral neutralizing antibody epitope mapping
IL314171A (en) * 2015-09-28 2024-09-01 Univ Florida Methods and compositions for antibody-evading virus vectors
WO2017197355A2 (en) * 2016-05-13 2017-11-16 4D Molecular Therapeutics Inc. Adeno-associated virus variant capsids and methods of use thereof
KR20200067195A (ko) * 2017-10-18 2020-06-11 리젠엑스바이오 인크. 완전-인간 번역후 변형된 항체 치료제

Similar Documents

Publication Publication Date Title
JP2024056895A5 (enExample)
JP2022068181A5 (enExample)
JP2022529631A5 (enExample)
JP2021118724A5 (enExample)
EP2660325A3 (en) AAV vectors and corresponding nucleotide sequences and methods
JP2022190081A5 (enExample)
JP2021514659A5 (enExample)
JP2021106619A5 (enExample)
JP2018510648A5 (enExample)
JP2021512649A5 (enExample)
JP2018522529A5 (enExample)
JP2020519284A5 (enExample)
JP2022549140A5 (enExample)
JP2022508182A5 (enExample)
JP2020505936A5 (enExample)
JP2020522269A5 (enExample)
JP2017509632A5 (enExample)
JP2022551744A5 (enExample)
JP2021516046A5 (enExample)
IL292264B1 (en) Aav transfer cassette
JP2019503649A5 (enExample)
JP2023515692A5 (enExample)
JP2017535266A5 (enExample)
JP2022524434A5 (enExample)
HRP20192141T1 (hr) Genska terapija za retinitis pigmentosa